Salarius Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Salarius Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.01M, a 60.3% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.22M, a 71.7% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$12.9M, a 59.5% increase from 2022.
  • Salarius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$31.8M, a 149% decline from 2021.
  • Salarius Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$12.8M, a 64.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.9M +$18.9M +59.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$31.8M -$19M -149% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 -$12.8M -$5.03M -64.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 -$7.79M +$479K +5.79% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 -$8.27M -$6.58M -391% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
2018 -$1.68M +$33M +95.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 -$34.7M +$5.16M +12.9% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$39.9M -$10.7M -36.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
2015 -$29.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.